To observe the additional pain sparing effect of a drug(tramadol) given as an injection in between two muscles in patients who undergo breast cancer surgery.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2019/03/018146
- Lead Sponsor
- Department of Anaesthesia and Intensive care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Females diagnosed with carcinoma breast.
2.American Society of Anaesthesiologists physical status 1-2.
3.Age 18-80 years
Exclusion Criteria
1.History of relevant drug allergy.
2.History of psychiatric illness, substance abuse.
3.Severe cardiovascular, respiratory, liver diseases, metabolic or neurological disease.
4.Chronic treatment with analgesics.
5.Pregnancy
6.Coagulopathy
7.Infection at planned injection site.
8.Psychological inability of the patient to understand Visual Analogue Scale.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative morphine consumption over 24 hours in patients receiving SAM block with or without tramadolTimepoint: Post-operative at 30mins,1hr,4hrs,8hrs,12hrs and 24hrs
- Secondary Outcome Measures
Name Time Method 1.Reduction in pain intensity by VAS score. <br/ ><br>2.Total dose of anti-emetics over 24hrs. <br/ ><br>3.Changes in haemodynamic variables. <br/ ><br>4.Any side effects pertaining to the procedure or drugs.Timepoint: 1.Post-operative at 30mins,1hr,4hrs,8hrs,12hrs and 24hrs. <br/ ><br>2.Post-operative at 30mins,1hr,4hrs,8hrs,12hrs and 24hrs <br/ ><br>3.Post-operative at 30mins,1hr,4hrs,8hrs,12hrs and 24hrs <br/ ><br>4.Post-operative at 30mins,1hr,4hrs,8hrs,12hrs and 24hrs